Monte Rosa Therapeutics
GLUE
#7469
Rank
C$0.43 B
Marketcap
$6.85
Share price
-2.17%
Change (1 day)
-10.79%
Change (1 year)

Earnings for Monte Rosa Therapeutics (GLUE)

Earnings in 2024 (TTM): -C$94.09 Million

According to Monte Rosa Therapeutics's latest financial reports the company's current earnings are C$75.62 Million. , an increase over its 2023 earnings that were of -C$0.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Monte Rosa Therapeutics from 2020 to 2024

Annual earnings

Year Earnings Change
2024 -C$97 Million-48.06%
2023 -C$0.19 Billion24.43%
2022 -C$0.16 Billion46.71%
2021 -C$0.11 Billion106.13%
2020 -C$49.63 Million